Financial Performance - Total revenue for Q3 2024 was ¥728,060,618.70, representing a year-over-year increase of 1.45%[2] - Net profit attributable to shareholders was ¥100,427,916.04, a decrease of 9.05% compared to the same period last year[2] - Net profit excluding non-recurring gains and losses was ¥96,272,689.05, down 12.07% year-over-year[2] - Basic earnings per share for the quarter was ¥0.65, with diluted earnings per share also at ¥0.65[3] - The total profit for Q3 2024 was approximately ¥335.36 million, a decrease from ¥360.61 million in Q3 2023, representing a decline of about 6.9%[16] - The net profit for Q3 2024 was approximately ¥294.45 million, down from ¥310.15 million in Q3 2023, reflecting a decrease of around 5.0%[16] - The basic and diluted earnings per share for Q3 2024 were both ¥1.91, compared to ¥2.00 in Q3 2023, indicating a decline of 4.5%[17] Cash Flow - Cash flow from operating activities was not applicable for the current period, but year-to-date cash flow was ¥250,321,229.74, a decrease of 45.44%[3] - The net cash flow from operating activities decreased by 45.44%, primarily due to increases in accounts receivable and financing receivables[8] - Cash flow from operating activities for the first nine months of 2024 was approximately ¥250.32 million, down from ¥458.80 million in the same period of 2023, a decrease of about 45.4%[17] - Cash inflow from investment activities in Q3 2024 was approximately ¥897.72 million, significantly higher than ¥22.37 million in Q3 2023[19] - Cash outflow from investment activities for Q3 2024 was approximately ¥1.81 billion, compared to ¥167.14 million in Q3 2023, resulting in a net cash flow from investment activities of approximately -¥908.53 million[19] - Cash flow from financing activities in Q3 2024 resulted in a net outflow of approximately -¥199.00 million, compared to a net inflow of ¥86.52 million in Q3 2023[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,625,739,782.58, a decrease of 0.45% from the end of the previous year[3] - Total equity attributable to shareholders was ¥3,193,585,894.27, down 0.74% compared to the previous year[3] - Cash and cash equivalents decreased by 37.40%, primarily due to an increase in fixed-term large deposits and the purchase of fixed assets[7] - Accounts receivable increased by 186.02%, mainly due to a decrease in customer prepayments[7] - Total liabilities increased marginally to CNY 1,432,153,888.31 from CNY 1,429,345,877.56, indicating a growth of 0.1%[14] Operating Performance - Operating revenue decreased by 1.62%, attributed to a decline in sales prices due to lower raw material costs[7] - Operating profit for the first three quarters of 2024 was CNY 337,032,339.54, compared to CNY 360,399,573.63 in the previous year, indicating a decline of approximately 6.5%[15] - The company reported a net profit margin of approximately 16.5% for the first three quarters of 2024, down from 17.4% in the same period of 2023[15] Investment and R&D - The company reported a 100% increase in investment income, attributed to financial management gains[7] - Research and development expenses for the first three quarters of 2024 were CNY 74,213,145.26, slightly down from CNY 74,889,407.84 in 2023, indicating a focus on maintaining R&D investment[15] Shareholder Information - The total number of common shareholders at the end of the reporting period was 16,068[9] - Government subsidies recognized in the current period totaled ¥2,842,110.00, contributing to the overall financial performance[4]
豪悦护理(605009) - 2024 Q3 - 季度财报